Eyenovia, Inc. (EYEN)
NASDAQ: EYEN · IEX Real-Time Price · USD
1.200
+0.090 (8.11%)
Jul 22, 2024, 10:26 AM EDT - Market open
Eyenovia Employees
Eyenovia had 57 employees as of December 31, 2023. The number of employees increased by 16 or 39.02% compared to the previous year.
Employees
57
Change (1Y)
16
Growth (1Y)
39.02%
Revenue / Employee
$154
Profits / Employee
-$569,190
Market Cap
75.27M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Burning Rock Biotech | 786 |
Champions Oncology | 230 |
Celularity | 225 |
Pro-Dex | 146 |
Precision BioSciences | 109 |
Connect Biopharma Holdings | 81 |
BioLineRx | 79 |
Vivani Medical | 44 |
EYEN News
- 21 days ago - NovaBay Pharmaceuticals and Eyenovia Commence Co-Promotion Activities - Business Wire
- 24 days ago - Eyenovia Announces Pricing of $5M Registered Direct Offering - GlobeNewsWire
- 2 months ago - Eyenovia Reports First Quarter 2024 Financial Results and Provides Updates on its Myopia Phase III Program and its Two FDA Approved Commercial Products, Mydcombi and Clobetasol - GlobeNewsWire
- 2 months ago - Eyenovia to Report First Quarter 2024 Results on Wednesday, May 15th - GlobeNewsWire
- 3 months ago - Eyenovia Provides Clinical and Scientific Update on FDA-Approved Products Mydcombi™ and Clobetasol Propionate Ophthalmic Suspension - GlobeNewsWire
- 3 months ago - Eyenovia Announces Updated Strategy and Corporate Priorities to Focus on Shareholder Value Generation and Immediate Commercial Opportunities - GlobeNewsWire
- 3 months ago - Eyenovia to Feature its Suite of Commercial Products and the Optejet Dispenser at Upcoming National Eyecare Meetings - GlobeNewsWire
- 4 months ago - Eyenovia Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update - GlobeNewsWire